Robbert M. Boudewijns

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

4-Octyl itaconate blocks STAT3-induced ACE2 expression to reduce uptake of SARS-CoV-2.

4-Octyl itaconate blocks STAT3-induced ACE2 expression to reduce uptake of SARS-CoV-2.

Journal: Biochemical pharmacology
Published: January 28, 2026

A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.

A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.

Journal: Journal of virology
Published: August 04, 2022

SARS-CoV-2 infection causes prolonged cardiomyocyte swelling and inhibition of HIF1α translocation in an animal model COVID-19.

SARS-CoV-2 infection causes prolonged cardiomyocyte swelling and inhibition of HIF1α translocation in an animal model COVID-19.

Journal: Frontiers in cardiovascular medicine
Published: June 08, 2022

The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution.

The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution.

Journal: Cardiovascular research
Published: April 29, 2022

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.

Journal: Frontiers in immunology
Published: December 30, 2021

Use of Micro-Computed Tomography to Visualize and Quantify COVID-19 Vaccine Efficiency in Free-Breathing Hamsters.

Use of Micro-Computed Tomography to Visualize and Quantify COVID-19 Vaccine Efficiency in Free-Breathing Hamsters.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 16, 2021

Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.

Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.

Journal: Emerging microbes & infections
Published: November 18, 2021

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.

Journal: Science translational medicine
Published: October 05, 2021

Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens".

Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens".

Journal: EBioMedicine
Published: June 29, 2021

The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model.

The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model.

Journal: Communications biology
Published: June 02, 2021

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters.

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters.

Journal: EBioMedicine
Published: February 26, 2021

A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice.

A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice.

Journal: JHEP reports : innovation in hepatology
Published: January 06, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026